Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-10-01

FDA Approved: LITHOBID — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Lithobid (lithium carbonate) submitted by ANI Pharmaceuticals, Inc. This action confirms approval of a supplemen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithobid (lithium carbonate)

Snippet

SUPPL AP for LITHOBID (LITHIUM CARBONATE)